Research and development focused on launching products ahead of the market and establishing them as de facto standards
First written in FY2016. 4 of 7 entries say "Restated". Latest entry: FY2025.
No other company in this theme has enough history to compare yet.
- FY2025ReframedAnnual report
「Based on its corporate philosophy, our group has established the following R&D guideline: “We aim to contribute to the healthcare field by creating highly versatile systems that remain relevant in an era of rapid change.”」
The wording shifted from emphasizing early product sales and de facto standard status to an R&D guideline centered on creating systems that can adapt to change and offer high versatility. - FY2024ReframedAnnual report
「“Proposal for the PSS Biosystems Concept: Systems made possible by simple technology that are highly precise, compact, highly versatile, and easy to maintain. We will create user-friendly, open systems for a wide range of fields.”」
The wording shifted from emphasizing early product sales and de facto standard status to an R&D concept emphasizing high precision, compactness, versatility, ease of maintenance, and open systems. - FY2020RestatedAnnual report
「To achieve this, our group believes that R&D activities should focus on launching highly refined products ahead of the market, anticipating market demand, and achieving de facto standard status as a result.」
The R&D policy of emphasizing early product sales and achieving de facto standard status by anticipating demand remained in place. - FY2019RestatedAnnual report
「We believe that R&D activities should focus on launching highly refined products ahead of the market, anticipating market demand, and achieving de facto standard status as a result.」
The R&D policy of emphasizing early product sales and achieving de facto standard status by anticipating demand was reconfirmed. - FY2018RestatedAnnual report
「We believe that R&D activities should focus on launching highly refined products ahead of the market, anticipating market demand, and achieving de facto standard status as a result.」
The R&D policy of emphasizing early product sales and achieving de facto standard status by anticipating demand was reconfirmed. - FY2017RestatedAnnual report
「We believe that R&D activities should focus on launching highly refined products ahead of the market, anticipating market demand, and achieving de facto standard status as a result.」
The R&D policy of emphasizing early product sales and achieving de facto standard status by anticipating demand was reiterated. - FY2016First statedAnnual report
「We believe that R&D activities should focus on launching highly refined products ahead of the market, anticipating market demand, and achieving de facto standard status as a result.」
An R&D approach focused on launching products ahead of the market, anticipating demand, and pursuing standardization.